Fairmount Funds Management LLC logo

Fairmount Funds Management LLC Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for Fairmount Funds Management LLC with $1.1B in long positions as of Q3 2025, 80% allocated to Healthcare, and 78% concentrated in top 10 positions.

Portfolio Value
$1.1B
Top 10 Concentration
78%
Top Sector
Healthcare (80%)
US Exposure
94%
Market Cap Focus
Mid Cap
Countries
2

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 80.40%Healthcare
Healthcare
80.40%

Industry Breakdown

1 industry across all sectors

Biotechnology: 80.37%Biotechnology
Biotechnology
Healthcare
80.37%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Mid Cap ($2B - $10B): 45.83%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 40.06%Small Cap ($300M - $2B)Micro Cap ($50M - $300M): 4.88%Nano Cap (< $50M): 3.78%N/A (ETF or Unknown): 5.45%
Mid Cap ($2B - $10B)
45.83%
Small Cap ($300M - $2B)
40.06%
Micro Cap ($50M - $300M)
4.88%
Nano Cap (< $50M)
3.78%
N/A (ETF or Unknown)
5.45%

Portfolio Concentration

Top 10 Holdings %
77.9%
Top 20 Holdings %
100.0%
Top 50 Holdings %
100.0%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
93.81%
International
6.19%
Countries
2
Largest Int'l Market
Bermuda - 6.19%
United States of America
93.81% ($1.0B)
16 holdings
Bermuda
6.19% ($68.8M)
1 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
11.1 quarters
Avg. Top 20
9.1 quarters
Avg. All Positions
9.1 quarters
Median Holding Period
8 quarters
Persistence Rate
70.59%
Persistent Holdings Weight
83.56%
Persistent Positions
12
Longest Held
Axsome Therapeutics, Inc logo
Axsome Therapeutics, IncAXSM - 22 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
5.45%
Avg. Position Weight
5.88%
Largest Position
Dianthus Therapeutics, Inc. Common Stock logo
Dianthus Therapeutics, Inc. Common StockDNTH - 11.71%
Largest Ownership Stake
Jade Biosciences, Inc. Common Stock logo
Jade Biosciences, Inc. Common StockJBIO - 9.87%
Avg. Ownership Stake
4.64%
Ownership Stake >5%
9
Ownership Stake >1%
15

Historical (Since Q4 2019)

Avg. New Position
6.15%
Avg. Ownership Stake
3.78%
Largest Position
Insmed, Inc. logo
Insmed, Inc.INSM - 26.23% (Q4 2019)
Largest Ownership Stake
Dianthus Therapeutics, Inc. Common Stock logo
Dianthus Therapeutics, Inc. Common StockDNTH - 13.02% (Q3 2023)

Portfolio Turnover

Current Quarter

Turnover Ratio
6.3%
Value Traded
$69.66M
Positions Added
1
Positions Exited
1

Historical (Since Q4 2019)

Avg. Turnover Ratio
15.8%
Avg. Positions Added
3
Avg. Positions Exited
2
Highest Turnover
50.0%
Q4 2019
Lowest Turnover
3.5%
Q2 2020

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.